NL193820B - Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen. - Google Patents
Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.Info
- Publication number
- NL193820B NL193820B NL9401005A NL9401005A NL193820B NL 193820 B NL193820 B NL 193820B NL 9401005 A NL9401005 A NL 9401005A NL 9401005 A NL9401005 A NL 9401005A NL 193820 B NL193820 B NL 193820B
- Authority
- NL
- Netherlands
- Prior art keywords
- ibuprofen
- dosage form
- oral administration
- pharmaceutical dosage
- solid pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT93MI001325A IT1264856B1 (it) | 1993-06-21 | 1993-06-21 | Composizione farmaceutica ad attivita' analgesica |
ITMI931325 | 1993-06-21 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL9401005A NL9401005A (nl) | 1995-01-16 |
NL193820B true NL193820B (nl) | 2000-08-01 |
NL193820C NL193820C (nl) | 2000-12-04 |
Family
ID=11366436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL9401005A NL193820C (nl) | 1993-06-21 | 1994-06-20 | Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen. |
Country Status (15)
Country | Link |
---|---|
US (2) | US5500226A (nl) |
JP (1) | JPH07101855A (nl) |
BE (1) | BE1007194A3 (nl) |
CA (1) | CA2125643C (nl) |
CH (1) | CH687850A5 (nl) |
DE (1) | DE4420856A1 (nl) |
DK (1) | DK174687B1 (nl) |
ES (1) | ES2099021B1 (nl) |
FR (1) | FR2706892B1 (nl) |
GB (1) | GB2279250B (nl) |
HU (1) | HU211669A9 (nl) |
IT (1) | IT1264856B1 (nl) |
NL (1) | NL193820C (nl) |
NO (1) | NO310443B1 (nl) |
SE (1) | SE9402157L (nl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1264856B1 (it) * | 1993-06-21 | 1996-10-17 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
US5654334A (en) * | 1995-06-23 | 1997-08-05 | Oklahoma Medical Research Foundation | Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester |
US5707967A (en) * | 1995-10-27 | 1998-01-13 | Vanmoor; Arthur | Pain relief compositions |
US6177467B1 (en) | 1996-09-26 | 2001-01-23 | Oklahoma Medical Research Foundation | Use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester and its derivatives in disease regression |
AU3221599A (en) | 1998-04-03 | 1999-10-25 | Daily Wellness Company, The | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation |
IT1301966B1 (it) * | 1998-07-30 | 2000-07-20 | Zambon Spa | Composizioni farmaceutiche ad attivita' analgesica |
KR100523242B1 (ko) * | 2000-05-18 | 2005-10-24 | 한미약품 주식회사 | 이부프로펜을 함유하는 정제 조성물 |
US20020192161A1 (en) * | 2001-04-10 | 2002-12-19 | Fahkreddin Jamali | Animal model for evaluating analgesics |
US6727286B2 (en) | 2001-11-02 | 2004-04-27 | Cumberland Pharmaceuticals Inc. | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
US20050137262A1 (en) * | 2003-12-22 | 2005-06-23 | Hu Patrick C. | Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
KR100678837B1 (ko) * | 2005-01-03 | 2007-02-05 | 한미약품 주식회사 | 활성 성분으로 덱시부프로펜을 함유하는 시럽제 조성물 및그의 제조 방법 |
KR100730393B1 (ko) | 2005-06-10 | 2007-06-20 | 한국콜마 주식회사 | 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법 |
ES2303468B1 (es) * | 2007-01-22 | 2009-06-08 | Masterfarm, S.L | "una composicion farmaceutica pulverulenta que comprende ibuprofeno". |
MX2010004974A (es) * | 2010-05-04 | 2011-11-23 | Senosiain S A De C V Lab | Combinacion de un aine y un aminoacido. |
KR101890649B1 (ko) * | 2013-07-30 | 2018-09-28 | 라이온 가부시키가이샤 | 정제 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1209667B (it) * | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
IT1197038B (it) * | 1986-08-01 | 1988-11-25 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
ATE50493T1 (de) * | 1986-11-14 | 1990-03-15 | Puetter Medice Chem Pharm | Ibuprofen enthaltendes arzneimittel. |
US4851444A (en) * | 1987-07-10 | 1989-07-25 | Analgesic Associates | Onset-hastened/enhanced analgesia |
US5262179A (en) * | 1989-09-13 | 1993-11-16 | Nicholas Kiwi Pty Ltd. | Non-effervescent ibuprofen compositions |
ATE128452T1 (de) * | 1989-10-17 | 1995-10-15 | Merck & Co Inc | S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential. |
IT1264856B1 (it) * | 1993-06-21 | 1996-10-17 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
-
1993
- 1993-06-21 IT IT93MI001325A patent/IT1264856B1/it active IP Right Grant
-
1994
- 1994-05-20 BE BE9400520A patent/BE1007194A3/fr not_active IP Right Cessation
- 1994-05-30 CH CH01671/94A patent/CH687850A5/it not_active IP Right Cessation
- 1994-05-31 GB GB9410898A patent/GB2279250B/en not_active Expired - Lifetime
- 1994-06-03 FR FR9406818A patent/FR2706892B1/fr not_active Expired - Lifetime
- 1994-06-07 US US08/255,776 patent/US5500226A/en not_active Expired - Lifetime
- 1994-06-10 CA CA002125643A patent/CA2125643C/en not_active Expired - Lifetime
- 1994-06-15 DE DE4420856A patent/DE4420856A1/de not_active Ceased
- 1994-06-20 DK DK199400725A patent/DK174687B1/da active
- 1994-06-20 NL NL9401005A patent/NL193820C/nl not_active IP Right Cessation
- 1994-06-20 NO NO19942343A patent/NO310443B1/no not_active IP Right Cessation
- 1994-06-20 JP JP6136834A patent/JPH07101855A/ja active Pending
- 1994-06-20 SE SE9402157A patent/SE9402157L/xx not_active Application Discontinuation
- 1994-06-20 ES ES09401335A patent/ES2099021B1/es not_active Expired - Fee Related
-
1995
- 1995-06-27 HU HU95P/P00467P patent/HU211669A9/hu unknown
- 1995-10-27 US US08/549,206 patent/US5645857A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB2279250B (en) | 1998-02-25 |
NL9401005A (nl) | 1995-01-16 |
JPH07101855A (ja) | 1995-04-18 |
CA2125643A1 (en) | 1994-12-22 |
DE4420856A1 (de) | 1994-12-22 |
US5645857A (en) | 1997-07-08 |
NO942343D0 (nl) | 1994-06-20 |
NO310443B1 (no) | 2001-07-09 |
SE9402157D0 (sv) | 1994-06-20 |
ES2099021A1 (es) | 1997-05-01 |
CH687850A5 (it) | 1997-03-14 |
IT1264856B1 (it) | 1996-10-17 |
BE1007194A3 (fr) | 1995-04-18 |
SE9402157L (sv) | 1994-12-22 |
DK72594A (da) | 1994-12-22 |
FR2706892B1 (nl) | 1995-10-20 |
US5500226A (en) | 1996-03-19 |
NO942343L (no) | 1994-12-22 |
NL193820C (nl) | 2000-12-04 |
HU211669A9 (en) | 1995-12-28 |
ITMI931325A0 (it) | 1993-06-21 |
ITMI931325A1 (it) | 1994-12-21 |
CA2125643C (en) | 2007-09-04 |
GB9410898D0 (en) | 1994-07-20 |
GB2279250A (en) | 1995-01-04 |
FR2706892A1 (nl) | 1994-12-30 |
ES2099021B1 (es) | 1998-01-16 |
DK174687B1 (da) | 2003-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ1876A1 (fr) | Médicaments pour administration orale. | |
BR9607862A (pt) | Composição farmacêutica filmogênica para administração transdérmica | |
FR2683146B1 (fr) | Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse. | |
ATE219377T1 (de) | Neue galenische orale pharmazeutische formulierung | |
ATE312602T1 (de) | Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung | |
NO961136D0 (no) | Farmasöytisk formuleringsgrunnlag for nano-suspensjoner | |
EE200000395A (et) | Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm | |
MA26456A1 (fr) | Formulations pharmaceutiques pour la distribution prolongee de medicament. | |
KR970006279A (ko) | 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물 | |
FI954767A (fi) | Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus | |
NL193820B (nl) | Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen. | |
DK0956010T3 (da) | Farmaceutiske mikrosfærer indeholdende valproinsyre til oral administrering | |
DZ1559A1 (fr) | Compositions pharmaceutiques. | |
PT835103E (pt) | Nanoparticulas para administracao oral de agentes farmaceuticos de baixa solubilidade | |
IT9019112A1 (it) | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina | |
DZ1926A1 (fr) | Formulations pharmaceutiques. | |
NO892764D0 (no) | Medikamentell administreringsform for droevtyggere. | |
BR9607433A (pt) | Composição farmacêutica para administração parental | |
FI952377A0 (fi) | Farmaseuttisia ibuprofeenikoostumuksia | |
IT8421874A0 (it) | Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno. | |
IT9021021A0 (it) | Composizioni farmaceutiche per la somministrazione orale di irudina | |
NO980384D0 (no) | Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler | |
DE19681529D2 (de) | Pharmazeutische Darreichungsform | |
ITMI992736A0 (it) | Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi | |
FI973277A0 (fi) | Farmaseuttisia valmisteita TNF:n estämiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Effective date: 20140620 |